openPR Logo
Press release

3D Cell Culture Market Analysis - 2026: Research Methodology Focuses on Exploring Major Factors Influencing the Industry Development, Appraised By Global Players 3D Biotek, Advanced Biomatrix, Becton and Dickinson Company (BD), Thermo Fisher scientific In

01-28-2019 08:20 AM CET | Health & Medicine

Press release from: Coherent Market Insights - Biotechnology Industry

Global 3D Cell Culture Market

Global 3D Cell Culture Market

3D cell culture is group of biological cells that are allowed to grow in artificial media in all three dimensions. It is used in drug discovery and tissue engineering, owing to their property of providing predictive data for in vivo tests and physiologically relevant information. 3D cell cultures have more stability and longer lifespan as compared to 2D cell culture system, which makes them suitable for long term studies long term effects of the drug on cells. 3D cell culture systems are mostly grown in bioreactors or 3D cell colonies. Studies have reported that they function similar to natural cells due to which they have applications in cancer research.

Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/534

Increasing adoption of 3D cell culture by cancer research organizations is expected to drive growth of 3D cell culture market:

High prevalence of various types of cancers and the need for affordable and effective treatment are the major factor driving growth of the 3D cell culture system market. For instance, according to the data published by World Health Organization (WHO), cancer accounted for 8.8 million of deaths worldwide in 2015. Increasing investment in healthcare, development of optimized 3D assays, R&D, and other research related activities are also fuelling growth of 3D cell culture market. The 3D cultures is majorly used for testing efficiency of new drug molecule, which can be used for treatment of chronic diseases. This increases adoption of 3D cell culture by pharmaceuticals and biotechnology industries, which in turn is driving growth of 3D cell culture market.

Increasing investment by government and private companies in novel drug discovery is expected to drive growth of 3D cell culture market in Asia Pacific:

Regional segmentation of 3D cell culture market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Africa, and Middle East. Advances in drug discovery is the major factor driving growth of the market in Asia Pacific region. Increasing government investments in healthcare sector, low operating costs of industries, investments by pharmaceutical and analytical instrumental companies in 3D cell culture projects to meet the demand for cancer treatments and organs development are some other factors fuelling growth of 3D cell culture market in this region.

Major players in market are focused on providing the product according to specific requirements of researchers. For instance, Thermo Fisher scientific has collaborated with Applikon Biotechnology and launched new single use bioreactor controller platforms-i-control and ez-control. Whereas the novel concept of customized 3D cell culture product has helped the small companies to enter in 3D cell culture industry. Major market players are adopting strategies such as agreement and partnership to maintain the leading position in market. For instance, Lonza Group Ltd. has expanded presence in the 3D cell culture market by signing an agreement with TAP Biosystems to distribute the RAFT 3D cell culture systems.

Key players operating the 3D cell culture market includes 3D Biotek, Advanced Biomatrix, Becton and Dickinson Company (BD), corning Incorporated, Global cell solutions Inc., Thermo Fisher scientific Inc., VWR Corporation, Nanofiber solutions, Lonza Group Ltd., Synthecon incorporated, and Tecan Trading AG.

Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/3d-cell-culture-market-534

3D Cell Culture Market Taxonomy:

The global 3D cell culture market is segmented on the basis of Product Type And Application

On the basis of Product Type - Scaffold based platforms, Macro-Porous scaffolds, Micro porous scaffolds, Nano porous scaffolds, Scaffold free platforms, Solid scaffolds, Bioreactors, Gels, Microchips, Services

On the basis of Application - Drug Discovery, Stem cell research, Cancer research, Regenerative medicine

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 3D Cell Culture Market Analysis - 2026: Research Methodology Focuses on Exploring Major Factors Influencing the Industry Development, Appraised By Global Players 3D Biotek, Advanced Biomatrix, Becton and Dickinson Company (BD), Thermo Fisher scientific In here

News-ID: 1536669 • Views:

More Releases from Coherent Market Insights - Biotechnology Industry

CRISPR and CAS Gene Market – Insights By Top Key Players: Caribou Biosciences Inc., CRISPR Therapeutics, Mirus Bio LLC, Editas Medicine, Takara Bio Inc., Synthego, Thermo Fisher Scientific, Inc
CRISPR and CAS Gene Market – Insights By Top Key Players: Caribou Biosciences …
Manufacturers in the CRISPR and CAS gene are collaborating with many companies for sponsoring clinical trials. Editas Medicine has licensed CRISPR and other gene editing patent rights from the Broad Institute, the Massachusetts Institute of Technology (MIT), Harvard University, and others. In March 2017, Editas reportedly entered into an agreement with Irish pharmaceutical company Allergan under, which Editas was to receive a US$ 90 million up-front payment for an option
Monoclonal Antibody Therapeutics - launch of novel monoclonal antibodies: Pfizer, Inc., Novartis International AG, Amgen, Inc., Sanofi S.A., Merck & Co., Inc., GlaxoSmithKline Plc
Monoclonal Antibody Therapeutics - launch of novel monoclonal antibodies: Pfizer …
Introduction and supposed success of monoclonal antibodies and other biological products has spurred the interest of manufacturers in these therapies. Success of popular monoclonal antibodies such as Avastin, Herceptin, and Rituxan (revenues as US$ 6.8 Bn, US$ 7.1 Bn, and US$ 5.9 Bn respectively in 2017 globally) has spurred manufacturers’ interest in these therapies. Leading manufacturers have resorted to boosting pipeline through various ways such as merger and acquisitions, partnerships,
Recombinant Human Endostatin Market Witness Significant Growth | Pfizer Inc., Novus Biologicals, Biocon, Thermo Fisher Scientific, Yantai Medgenn Ltd., FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd
Recombinant Human Endostatin Market Witness Significant Growth | Pfizer Inc., No …
Increasing research and development activities for identifying potential uses of recombinant human endostatin is expected to propel growth of the market. For instance, according to a paper published in the journal Nature, September 2015, a study was conducted to evaluate effects of recombinant human endostatin in combination with radiotherapy for treating esophageal squamous cell carcinoma and to discover its potential mechanisms. These findings suggested that recombinant human endostatin is a
Monoclonal Antibody Diagnostic Reagents Market Dynamics 2019 By Key Pkayers: AnaSpec, BioGenex, Bio-Rad, Biocare Medical, BioVision, Celltrion, Creative Diagnostics, GenWay Biotech, Innovent Biologics
Monoclonal Antibody Diagnostic Reagents Market Dynamics 2019 By Key Pkayers: Ana …
Increasing use of monoclonal antibodies in various R&D applications, cancer therapies, and immunological disorders is expected to drive growth of the global monoclonal antibody diagnostic reagents market size. Monoclonal antibody diagnostic kits are increasingly used to detect communicable diseases including transfusion transmissible infections (TTI). According to World Health Organization (WHO) data of 2017, each year about

All 5 Releases


More Releases for Cell

Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic "Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445 Current
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939 This latest report researches the industry structure, sales, revenue,
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY